Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00323908
Recruitment Status : Completed
First Posted : May 10, 2006
Last Update Posted : February 7, 2012
Sponsor:
Collaborators:
University of Alabama at Birmingham
Avon Foundation
National Cancer Institute (NCI)
Johns Hopkins University
Information provided by (Responsible Party):
Carol Fabian, MD, University of Kansas Medical Center

Brief Summary:
A study to examine the correlations between methylation of various genes associated with breast cancer and proliferation and cytomorphology in breast epithelial cells acquired by random periareolar fine needle aspiration of women at high risk for development of breast cancer.

Condition or disease
Breast Cancer

Detailed Description:
A study to examine the correlation between gene promotor methylation and benign breast tissue proliferation and cytomorphology collected via random periareolar fine needle aspiration in postmenopausal women at increased risk for breast cancer.

Layout table for study information
Study Type : Observational
Actual Enrollment : 281 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: QM-MSP, Ki-67, and Cytomorphology of RPFNA Specimens From High Risk Women
Study Start Date : June 2005
Actual Primary Completion Date : November 2008
Actual Study Completion Date : November 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breast Cancer

Group/Cohort
1
Women at high risk for developing breast cancer




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
medical center
Criteria

Inclusion criteria:

  • women at high risk of developing breast cancer determined by family or personal history
  • willing to participate in companion protocol (KUMC HSC#4601) for random periareolar fine needle aspiration (RPFNA) for correlational studies

Exclusion criteria:

  • exclude women who have been on raloxifene, tamoxifen, letrozole, anastrozole or exemestane within the six months prior to RPFNA

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00323908


Sponsors and Collaborators
Carol Fabian, MD
University of Alabama at Birmingham
Avon Foundation
National Cancer Institute (NCI)
Johns Hopkins University
Investigators
Layout table for investigator information
Principal Investigator: Carol J Fabian, MD University of Kansas Medical Center
Layout table for additonal information
Responsible Party: Carol Fabian, MD, Professor, Director Breast Cancer Prevention Unit, University of Kansas Medical Center
ClinicalTrials.gov Identifier: NCT00323908    
Other Study ID Numbers: 9933
First Posted: May 10, 2006    Key Record Dates
Last Update Posted: February 7, 2012
Last Verified: February 2012
Keywords provided by Carol Fabian, MD, University of Kansas Medical Center:
Breast Cancer
prevention
tissue sampling
polymorphisms
steroid and carcinogen metabolism
Additional relevant MeSH terms:
Layout table for MeSH terms
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases